-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ST-316 in Metastatic Bile Duct Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ST-316 in Metastatic Bile Duct CancerDrug Details:ST-316 is under development for the treatment of breast cancer,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ST-316 in Metastatic Adenocarcinoma of The Pancreas
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ST-316 in Metastatic Adenocarcinoma of The PancreasDrug Details:ST-316 is under development for the treatment of breast...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ST-316 in Triple-Negative Breast Cancer (TNBC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ST-316 in Triple-Negative Breast Cancer (TNBC)Drug Details:ST-316 is under development for the treatment of breast cancer,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ST-316 in Metastatic Melanoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ST-316 in Metastatic MelanomaDrug Details:ST-316 is under development for the treatment of breast cancer, hematological tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ST-316 in Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ST-316 in Non-Small Cell Lung CancerDrug Details:ST-316 is under development for the treatment of breast cancer,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ST-316 in Metastatic Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ST-316 in Metastatic Colorectal CancerDrug Details:ST-316 is under development for the treatment of breast cancer, hematological...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ST-316 in Metastatic Ovarian Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ST-316 in Metastatic Ovarian CancerDrug Details:ST-316 is under development for the treatment of breast cancer, hematological...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ST-316 in Synovial Sarcoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ST-316 in Synovial SarcomaDrug Details:ST-316 is under development for the treatment of breast cancer, hematological tumors...
-
Product Insights
New![]()
Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Infusion Pumps Pipeline Market Report Overview Infusion Pumps are the drug delivery system that provides continuous infusion of an agent at a constant and precise rate. The Infusion Pumps pipeline market research report provides comprehensive information about the Infusion Pumps pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories · The US · Global · Israel · Singapore · Japan Key Regulatory Paths...
-
Sector Analysis
![]()
FIBA Men’s Basketball World Cup 2023 – Post Event Analysis
FIBA Men’s Basketball World Cup 2023 Report Overview The FIBA Men’s Basketball World Cup 2023 had an annual sponsorship value of $81,850,000. It was the most-attended World Cup game in the history of the tournament and had 41 agreed sponsorship deals. Nippon Life Insurance Company was a local event sponsor since Japan was one of the host nations of the tournament. The FIBA Men’s Basketball World Cup 2023 research report provides an analysis of the recent FIBA Men’s Basketball World...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.